Details for New Drug Application (NDA): 016954
✉ Email this page to a colleague
NDA 016954 describes MICRONOR, which is a drug marketed by Janssen Pharms and is included in one NDA. Additional details are available on the MICRONOR profile page.
The generic ingredient in MICRONOR is norethindrone. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
The generic ingredient in MICRONOR is norethindrone. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
Summary for 016954
| Tradename: | MICRONOR |
| Applicant: | Janssen Pharms |
| Ingredient: | norethindrone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016954
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-28 | Strength | 0.35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
